Two synthetic CBD analogues (PQM-242 and PQM-249) were over 13 times less toxic to brain cells than natural CBD while maintaining similar protective effects against alcohol-induced cell death.
Pharmaceutical researchers, addiction medicine specialists, and scientists studying CBD derivatives
What the researchers found
Synthetic CBD analogues PQM-242 and PQM-249 showed LC50 values >600 µM compared to CBD's 44 µM (>13x less toxic), with NOAELs of 100 µM vs. CBD's 10 µM, while still protecting against ethanol-induced apoptosis in neuronal cells.
Why it matters
CBD shows promise for alcohol use disorder but has a narrower safety window than assumed — these synthetic alternatives could provide the same benefits with a much wider margin of safety.
The numbers in context
CBD LC50: 44 µM; PQM-242 and PQM-249 LC50: >600 µM; CBD NOAEL: 10 µM; analogue NOAEL: 100 µM; ethanol challenge at 250 mM; PQM-242 additionally prevented Bax upregulation.
How the study worked
In vitro study comparing natural CBD with two synthetic derivatives in human SH-SY5Y neuroblastoma cells, assessing cytotoxicity (MTT), apoptosis (annexin V/PI), and Bax/Bcl-2 expression after 48-hour exposure and ethanol challenge.
What this study cannot tell us
In vitro neuroblastoma cell line; ethanol concentration (250 mM) is supraphysiological; does not address in vivo pharmacokinetics or behavioral outcomes.
How to read the evidence
In vitro study with clear dose-response data and mechanistic analysis, but very early-stage findings requiring in vivo validation.
When this study was published
Published in 2026, representing cutting-edge synthetic cannabinoid analogue development.
The bigger picture
If these synthetic analogues maintain their safety advantage in animal and human studies, they could become preferred therapeutics for alcohol use disorder — addressing a condition with limited pharmacological options.
Questions still open
- Will the improved safety profile of PQM-242/PQM-249 translate to in vivo models? Can these analogues cross the blood-brain barrier effectively?
Common questions
Are there safer alternatives to CBD?
Can CBD help with alcohol addiction?
Read the original research
Synthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells.
Neurotoxicology, 113, 103411
Citation
Almeida, Carolina Aparecida Faria; Salles, Gabriela; Bruno, Vitor; Ribeiro, Jessyca Milene; Silva, Alessandra Oliveira; de Assis Braz, Giulia; Castelhano, Felype Valentim Duarte; Dos Reis Rosa Franco, Graziella; Viegas, Cláudio; Marcourakis, Tania; Torres, Larissa Helena Lobo; Garcia, Raphael Caio Tamborelli. (2026). Synthetic cannabidiol analogues exhibit lower toxicity than cannabidiol and protect against ethanol-induced apoptosis in SH-SY5Y cells.. Neurotoxicology, 113, 103411. https://doi.org/10.1016/j.neuro.2026.103411
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk